↓ Skip to main content

Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei

Overview of attention for article published in Journal of Antimicrobial Chemotherapy (JAC), April 2005
Altmetric Badge

Mentioned by

wikipedia
1 Wikipedia page

Citations

dimensions_citation
72 Dimensions

Readers on

mendeley
46 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei
Published in
Journal of Antimicrobial Chemotherapy (JAC), April 2005
DOI 10.1093/jac/dki151
Pubmed ID
Authors

Vanaporn Wuthiekanun, Allen C Cheng, Wirongrong Chierakul, Premjit Amornchai, Direk Limmathurotsakul, Wipada Chaowagul, Andrew J H Simpson, Jennifer M Short, Gumphol Wongsuvan, Bina Maharjan, Nicholas J White, Sharon J Peacock

Abstract

Trimethoprim/sulfamethoxazole is commonly used to treat melioidosis. Antimicrobial susceptibility testing using the disc diffusion method is commonly used in melioidosis-endemic areas, but may overestimate resistance to trimethoprim/sulfamethoxazole.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Thailand 1 2%
Unknown 44 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 17%
Student > Ph. D. Student 7 15%
Researcher 6 13%
Student > Bachelor 5 11%
Other 2 4%
Other 7 15%
Unknown 11 24%
Readers by discipline Count As %
Medicine and Dentistry 13 28%
Biochemistry, Genetics and Molecular Biology 9 20%
Agricultural and Biological Sciences 9 20%
Immunology and Microbiology 1 2%
Decision Sciences 1 2%
Other 1 2%
Unknown 12 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 February 2010.
All research outputs
#8,544,090
of 25,394,764 outputs
Outputs from Journal of Antimicrobial Chemotherapy (JAC)
#3,494
of 8,177 outputs
Outputs of similar age
#25,550
of 72,898 outputs
Outputs of similar age from Journal of Antimicrobial Chemotherapy (JAC)
#20
of 66 outputs
Altmetric has tracked 25,394,764 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,177 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.9. This one is in the 35th percentile – i.e., 35% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 72,898 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 66 others from the same source and published within six weeks on either side of this one. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.